Literature DB >> 18678385

Determinants of cyclophilin A-dependent TRIM5 alpha restriction against HIV-1.

Tsai-Yu Lin1, Michael Emerman.   

Abstract

TRIM5 alpha is a host protein that can bind to incoming retroviral capsid (CA) and inhibit retroviruses in a species-specific manner. The CA protein of HIV-1 also interacts with high affinity to the host protein cyclophilin A (CypA). This binding has been shown to positively affect some early stage of the viral life cycle in human cells. However, the CypA/CA interaction also renders HIV-1 more susceptible to rhesus TRIM5 alpha (rhTRIM5 alpha) restriction. We find that the ability of old world monkey TRIM5 alpha genes to restrict HIV-1 in a CypA-dependent manner is widespread. On the other hand, we find that simian immunodeficiency viruses from tantalus monkeys (SIVagmTAN), is unlike HIV-1 in that CypA does not enhance the rhTRIM5 alpha restriction against the virus even though the CA of this virus, like HIV-1, does bind CypA. Mapping of the determinants for this phenotype by swapping regions on CA between SIVagmTAN and HIV-1 showed that when SIVagmTAN contains loops between helices 4/5 (4-5 loop) and 6/7 (6-7 loop) from HIV-1 CA, it becomes susceptible to the CypA-enhanced rhTRIM5 alpha restriction. Surprisingly, when SIVagmTAN contains either loop from HIV-1 CA, it gains sensitivity to TRIM5 alpha from species which originally have no effect on the wild-type virus. Moreover, we find that CypA/CA interaction occurs early after viral entry but the CypA-enhanced restriction mostly acts on the stage after reverse transcription.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18678385      PMCID: PMC2615586          DOI: 10.1016/j.virol.2008.06.037

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  42 in total

1.  A quantitative assay for HIV DNA integration in vivo.

Authors:  S L Butler; M S Hansen; F D Bushman
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

2.  Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding.

Authors:  U O'Doherty; W J Swiggard; M H Malim
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins.

Authors:  Jenny L Anderson; Edward M Campbell; Xiaolu Wu; Nick Vandegraaff; Alan Engelman; Thomas J Hope
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 4.  Intrinsic immunity: a front-line defense against viral attack.

Authors:  Paul D Bieniasz
Journal:  Nat Immunol       Date:  2004-11       Impact factor: 25.606

5.  Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity.

Authors:  Zuzana Keckesova; Laura M J Ylinen; Greg J Towers
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

6.  Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells.

Authors:  Elena Sokolskaja; Lionel Berthoux; Jeremy Luban
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

7.  The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha.

Authors:  Hassan Javanbakht; Felipe Diaz-Griffero; Matthew Stremlau; Zhihai Si; Joseph Sodroski
Journal:  J Biol Chem       Date:  2005-05-15       Impact factor: 5.157

8.  Requirements for capsid-binding and an effector function in TRIMCyp-mediated restriction of HIV-1.

Authors:  Felipe Diaz-Griffero; Nick Vandegraaff; Yuan Li; Kathleen McGee-Estrada; Matthew Stremlau; Sohanya Welikala; Zhihai Si; Alan Engelman; Joseph Sodroski
Journal:  Virology       Date:  2006-05-02       Impact factor: 3.616

9.  Binding and susceptibility to postentry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type 1 capsid.

Authors:  Christopher M Owens; Byeongwoon Song; Michel J Perron; Peter C Yang; Matthew Stremlau; Joseph Sodroski
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.

Authors:  Matthew Stremlau; Christopher M Owens; Michel J Perron; Michael Kiessling; Patrick Autissier; Joseph Sodroski
Journal:  Nature       Date:  2004-02-26       Impact factor: 49.962

View more
  22 in total

1.  Functional evidence for the involvement of microtubules and dynein motor complexes in TRIM5α-mediated restriction of retroviruses.

Authors:  Paulina Pawlica; Valerie Le Sage; Nolwenn Poccardi; Michel J Tremblay; Andrew J Mouland; Lionel Berthoux
Journal:  J Virol       Date:  2014-03-05       Impact factor: 5.103

Review 2.  The innate immune roles of host factors TRIM5α and Cyclophilin A on HIV-1 replication.

Authors:  Yi-Qun Kuang; Hong-Liang Liu; Yong-Tang Zheng
Journal:  Med Microbiol Immunol       Date:  2015-04-19       Impact factor: 3.402

3.  Role of TRIM5α RING domain E3 ubiquitin ligase activity in capsid disassembly, reverse transcription blockade, and restriction of simian immunodeficiency virus.

Authors:  Jonghwa Kim; Christopher Tipper; Joseph Sodroski
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

4.  Homology-based identification of capsid determinants that protect HIV1 from human TRIM5α restriction.

Authors:  Pierre V Maillard; Vincent Zoete; Olivier Michielin; Didier Trono
Journal:  J Biol Chem       Date:  2010-12-17       Impact factor: 5.157

Review 5.  Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.

Authors:  Laurence Colin; Carine Van Lint
Journal:  Retrovirology       Date:  2009-12-04       Impact factor: 4.602

6.  Porcine endogenous retroviruses PERV A and A/C recombinant are insensitive to a range of divergent mammalian TRIM5alpha proteins including human TRIM5alpha.

Authors:  Andrew Wood; Benjamin L J Webb; Birke Bartosch; Torsten Schaller; Yasuhiro Takeuchi; Greg J Towers
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

Review 7.  Human cellular restriction factors that target HIV-1 replication.

Authors:  Klaus Strebel; Jeremy Luban; Kuan-Teh Jeang
Journal:  BMC Med       Date:  2009-09-16       Impact factor: 8.775

8.  Multiple sites in the N-terminal half of simian immunodeficiency virus capsid protein contribute to evasion from rhesus monkey TRIM5α-mediated restriction.

Authors:  Ken Kono; Haihan Song; Masaru Yokoyama; Hironori Sato; Tatsuo Shioda; Emi E Nakayama
Journal:  Retrovirology       Date:  2010-09-08       Impact factor: 4.602

9.  Cellular restriction targeting viral capsids perturbs human immunodeficiency virus type 1 infection of nondividing cells.

Authors:  Masahiro Yamashita; Michael Emerman
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

10.  Modification of a loop sequence between alpha-helices 6 and 7 of virus capsid (CA) protein in a human immunodeficiency virus type 1 (HIV-1) derivative that has simian immunodeficiency virus (SIVmac239) vif and CA alpha-helices 4 and 5 loop improves replication in cynomolgus monkey cells.

Authors:  Ayumu Kuroishi; Akatsuki Saito; Yasuhiro Shingai; Tatsuo Shioda; Masako Nomaguchi; Akio Adachi; Hirofumi Akari; Emi E Nakayama
Journal:  Retrovirology       Date:  2009-08-03       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.